1. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003;107:I9-I16. PMID:
12814980.
2. Lidegaard Ø, Edström B, Kreiner S. Oral contraceptives and venous thromboembolism: a five-year national case-control study. Contraception 2002;65:187-196. PMID:
11929640.
3. Donnelly JC, D’Alton ME. Pulmonary embolus in pregnancy. Semin Perinatol 2013;37:225-233. PMID:
23916021.
4. Sia WW, Powrie RO, Cooper AB, Larson L, Phipps M, Spencer P, et al. The incidence of deep vein thrombosis in women undergoing cesarean delivery. Thromb Res 2009;123:550-555. PMID:
18706683.
5. Giannubilo SR, Tranquilli AL. Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia. Curr Med Chem 2012;19:4562-4571. PMID:
22876895.
6. Bain E, Wilson A, Tooher R, Gates S, Davis LJ, Middleton P. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev 2014;CD001689PMID:
24519568.
7. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest 2008;133:844S-86S. PMID:
18574280.
8. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest 2012;141:e691S-e736S. PMID:
22315276.
9. Cohen AT. Asia-Pacific Thrombosis Advisory Board. Asia-Pacific Thrombosis Advisory Board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery. Thromb Haemost 2010;104:919-930. PMID:
20941466.
10. Hasegawa M, Wada H, Wakabayashi H, Yoshida K, Miyamoto N, Asanuma K, et al. The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery. Clin Chim Acta 2013;425:109-113. PMID:
23876378.
11. Hosaka K, Saito S, Ishii T, Sumino T, Ryu K, Suzuki G, et al. Safety of fondaparinux versus enoxaparin after TKA in Japanese patients. Orthopedics 2013;36:e428-33. PMID:
23590781.
12. James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol 2009;29:326-331. PMID:
19228606.
13. Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest 2009;135:513-520. PMID:
19201714.
14. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006;194:1311-1315. PMID:
16647915.
15. Cavazza S, Rainaldi MP, Adduci A, Palareti G. Thromboprophylaxis following cesarean delivery: one site prospective pilot study to evaluate the application of a risk score model. Thromb Res 2012;129:28-31. PMID:
21840574.
16. Gader AA, Haggaz AE, Adam I. Epidemiology of deep venous thrombosis during pregnancy and puerperium in Sudanese women. Vasc Health Risk Manag 2009;5:85-87. PMID:
19436646.
17. Zhi-jian S, Yu Z, Giu-xing Q, Yi-peng W, Xi-sheng W, Hong Z, et al. Efficacy and safety of low molecular weight heparin prophylaxis for venous thromboembolism following lumbar decompression surgery. Chin Med Sci J 2011;26:221-226. PMID:
22218049.
18. Carlson MK, Gleason PP, Sen S. Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity. Pharmacotherapy 2001;21:108-113. PMID:
11191729.
19. Schünemann HJ, Cook D, Guyatt G. Methodology for antithrombotic and thrombolytic therapy guideline development: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th Edition). Chest 2008;133:113S-122S. PMID:
18574261.
20. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:160S-198S. PMID:
18574265.
21. Johnson PN, Benefield EC, Bui PY, Marlar RA, Gessouroun MR. Fondaparinux in an obese child with heparin-induced thrombocytopenia and a history of renal failure. J Pediatr Pharmacol Ther 2013;18:303-310. PMID:
24719591.
22. Ciurzyński M, Jankowski K, Pietrzak B, Mazanowska N, Rzewuska E, Kowalik R, et al. Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia. Med Sci Monit 2011;17:CS56-CS59. PMID:
21525816.
23. Parody R, Oliver A, Souto JC, Fontcuberta J. Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. Haematologica 2003;88:ECR32PMID:
14607764.